Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients
Clinical trial NCT03617432 · UNKNOWN
Trial details
- NCT number
- NCT03617432
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-28
- Primary completion
- 2020-09-30
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.